Silence Therapeutics (SLN) Shares Outstanding (2019 - 2025)
Historic Shares Outstanding for Silence Therapeutics (SLN) over the last 5 years, with Q3 2025 value amounting to $141.7 million.
- Silence Therapeutics' Shares Outstanding fell 2300.43% to $141.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $141.7 million, marking a year-over-year decrease of 2300.43%. This contributed to the annual value of $141.7 million for FY2024, which is 395.44% down from last year.
- Latest data reveals that Silence Therapeutics reported Shares Outstanding of $141.7 million as of Q3 2025, which was down 2300.43% from $141.7 million recorded in Q2 2025.
- Silence Therapeutics' 5-year Shares Outstanding high stood at $184.0 million for Q3 2024, and its period low was $121.0 million during Q4 2021.
- For the 5-year period, Silence Therapeutics' Shares Outstanding averaged around $150.0 million, with its median value being $141.7 million (2025).
- Per our database at Business Quant, Silence Therapeutics' Shares Outstanding skyrocketed by 1665.11% in 2023 and then crashed by 2300.43% in 2025.
- Quarter analysis of 5 years shows Silence Therapeutics' Shares Outstanding stood at $121.0 million in 2021, then increased by 4.48% to $126.5 million in 2022, then rose by 16.65% to $147.5 million in 2023, then decreased by 3.95% to $141.7 million in 2024, then increased by 0.02% to $141.7 million in 2025.
- Its Shares Outstanding was $141.7 million in Q3 2025, compared to $141.7 million in Q2 2025 and $141.7 million in Q1 2025.